Cite
HARVARD Citation
Ludolph, A. et al. (2018). Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial. Lancet neurology. 17 (8), pp. 681-688. [Online].